Older age and certain underlying health conditions, such as diabetes, cardiovascular disease, and obesity, have been identified as factors that can influence the ACE2 expression levels, which may contribute to increased susceptibility and more severe COVID-19 outcomes in these populations. Here, ACE2 is linked to cardiovascular disorder.